ALBO
Albireo Pharma Inc
ALBO
ALBO
Delisted
ALBO was delisted on the 2nd of March, 2023.
96 hedge funds and large institutions have $396M invested in Albireo Pharma Inc in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 41 increasing their positions, 31 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
11% less funds holding
Funds holding: 108 → 96 (-12)
58% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 19
Holders
96
Holding in Top 10
4
Calls
$1.25M
Puts
$931K
Top Buyers
| 1 | +$12.5M | |
| 2 | +$5.65M | |
| 3 | +$5.13M | |
| 4 |
BlackRock
New York
|
+$2.74M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.22M |
Top Sellers
| 1 | -$14.5M | |
| 2 | -$12.7M | |
| 3 | -$6.37M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$5.23M |
| 5 |
MCM
MAI Capital Management
Independence,
Ohio
|
-$2.99M |